Navigation Links
Third generation Small pox vaccine from Cell-culture

Richard Greenberg and colleagues compared their Cell culture small pox vaccine// (CCSV) derived from cell culture with calf lymph derived vaccine. Small pox vaccine currently used is a live, attenuated vaccine virus derived from calf lymph. This vaccine produces adverse effects in vaccinated, 15-42 develop serious or life threatening adverse reactions of every million. 1 to 2 people every million die because of this vaccine. Serious side include eczema vaccinatum, progressive vaccinia, post vaccinal encephalitis, fetal vaccine, vaccina keratitis, myopericarditis.

Small pox vaccine is contraindicated in up to 30% or more population, including infants, pregnant women, immunocompromised, eczema patients, and cardiovascular conditions.

In this trial, the safety and immunogenecity, adverse effects were determined by neutralization, Antibody titers, T-cell proliferative response assays and interferon-? elispot. Only one vaccinated person developed pock lesions. The number of participants who became immune to the virus was high, with increased measures of cell mediated immunity in CCSV recipients. These results show CCSV vaccine is equally immunogenic and safe compared to calf lymph derived vaccine.

This new vaccine can solve the problem of calf lymph vaccine, as these existing stocks of calf lymph vaccine are mot than 20 years old, contamination by bovine prions can be avoided, unwanted immune response to bovine and other non-vaccina entities in vaccine.

Though, CCSV has advantages, we should be able to provide universal pre-exposure immunity to small pox. A safe, immunogenic, effective vaccine will provide a barrier against attempts to use small pox as a biological weapon. Research leading to the third generation vaccines, such as vaccinia viruses that are further attenuated, inactivated viruses, subunit or peptide based vaccines should have significant use to public health.


'"/>




Page: 1

Related medicine news :

1. Third artificial heart patient introduced
2. Surgery Offers Better Treatment For Third Degree Piles
3. One Third Of All Cancers Preventable!
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Kleins Third Way Has Tough Opposition
6. Ignorance about AIDS rampart in Third of College Students: Chinese survey
7. Jalgaon: Third Phase Of Culling Operations Begin
8. Pramod Mahajan Undergoes Third Surgery
9. Third Arm Removed Successfully
10. Erection Drug Was Not Useful to Two-Thirds of Its Users
11. Babies Could Be exposed to Third Hand Smoke If Parents Are Smokers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: